Prachi Patel-Predd

Companies in the news: 1) AVAX and CTCA Collaborating for Cancer Therapies 2) Full Speed Ahead for GPC Biotech's Satraplatin 3) Bristol-Myers Squibb Company / Adnexus Therapeutics: Collaboration for New Oncology Compounds 4) Graffinity and Amgen in Drug Discovery Agreement 5) Roche Suspends Enrollment in CERA Phase II Oncology Trial

This month's Fed Focus highlights such topics as Medicare reimbursement for cancer care and NCI budget cuts that affect cancer research. From "The State House" and Justice Department, we cover the HPV vaccine mandate and a governor under fire as well as state laws requiring colon cancer screening coverage. Reimbursment, NCI budget cuts, and more

News reports featured in this issue: 1) Breast Cancer Spotlight 2) Expert Cancer Centers Cost-Effective for Managing Ovarian Cancer 3) New Breathalyzer "Smells" Lung Cancer in Early Stages 4) PSA Adjusted for Prostate Size is Possible Identifier of Men at Risk for Developing Life-Threatening Cancer

With FDA approval for their advanced breast cancer drug Tykerb�®, GlaxoSmithKline is poised to reposition itself as a major player in the oncology business.

This month's Fed Focus highlights the CDC's HPV vaccine recommendations as well as changes in Medicare coverage of ESAs for cancer-related anemia. Our reports from "The State House" indicate that, even with the CDC's HPV vaccine recommendations, some resistance is expected at the state level.

GlaxoSmithKline's experimental cervical cancer vaccine Cervarix has proven 100% effective in preventing precancerous lesions due to cancer-causing human papillomavirus (HPV) strains 16 and 18 for up to five and a half years.

Two separate studies show the relationship between hormone replacement therapy and women's cancers.

The Academy delivers the latest news on biotechand oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery. In this issue: Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Harvard Medical School, Boston; Dana-Farber Cancer Institute, Boston; Yale School of Medicine, New Haven; and Robert Wood Johnson Medical School,Piscataway, NJ.